R&D

News

Alexion joins with Dicerna to develop RNAi therapies for com...

Alexion has announced a collaboration with Dicerna Pharmaceuticals to discover and develop RNA interference therapies for diseases caused by problems in the complement system.

News

Innate Pharma gains rights to AZ's recently approved leukaem...

France’s Innate Pharma has gained rights to AstraZeneca's recently approved leukaemia drug Lumoxiti, in a deal that expands a collaboration that began more than three years ago.

Partner Content

Partner Content

Overcoming bottlenecks in early drug discovery with the powe...

Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry

News

Merck KGaA's BTK drug reduces lesions in relapsing MS patien...

Germany’s Merck KGaA has said it is “encouraged” by mid-stage trial results showing that its Bruton’s kinase (BTK) class drug evobrutinib reduced occurrence of central nervous system lesion

News